Protective role of macrophage-derived ceruloplasmin in inflammatory bowel disease

Gut

Volumn 62, Issue 2, 2013, Pages 209-219

  Bakhautdin, Bakytzhan ^a,b   Febbraio, Maria ^a   Goksoy, Esen ^a   De La Motte, Carol A ^a   Gulen, Muhammet F ^a   Childers, Erin Patricia ^a   Hazen, Stanley L ^a   Li, Xiaoxia ^a   Fox, Paul L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; CERULOPLASMIN; DEXTRAN SULFATE; KERATINOCYTE DERIVED CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BONE MARROW TRANSPLANTATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; ENTERITIS; FEMALE; HISTOPATHOLOGY; LEUKOCYTOSIS; MACROPHAGE; MACROPHAGE MIGRATION; MONOCYTE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; SUPERNATANT; SURVIVAL RATE; TISSUE CULTURE; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; BONE MARROW TRANSPLANTATION; CERULOPLASMIN; CHEMOKINES; COLITIS; DEXTRAN SULFATE; DISEASE PROGRESSION; DNA PRIMERS; FEMALE; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; PROTEIN CARBONYLATION; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84872086586     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-300694     Document Type: Article

References (53)

1. Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999;11:648-56.
2. Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 2009;44:431-40.
3. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. BMJ 1955;2:1041-8.
4. Schenk M, Mueller C. Adaptations of intestinal macrophages to an antigen-rich environment. Semin Immunol 2007;19:84-93. (Pubitemid 46810284)
5. Kamada N, Hisamatsu T, Okamoto S, et al. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J Clin Invest 2008;118:2269-80. (Pubitemid 351872344)
6. Vassiliev V, Harris ZL, Zatta P. Ceruloplasmin in neurodegenerative diseases. Brain Res Brain Res Rev 2005;49:633-40. (Pubitemid 41546662)
7. Yang F, Naylor SL, Lum JB, et al. Characterization, mapping, and expression of the human ceruloplasmin gene. Proc Natl Acad Sci U S A 1986;83:3257-61. (Pubitemid 16043016)
8. Gitlin JD. Transcriptional regulation of ceruloplasmin gene expression during inflammation. J Biol Chem 1988;263:6281-7.
9. Mazumder B, Mukhopadhyay CK, Prok A, et al. Induction of ceruloplasmin synthesis by IFN-gamma in human monocytic cells. J Immunol 1997;159:1938-44. (Pubitemid 127484183)
10. Osaki S, Johnson DA, Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem 1966;241:2746-51.
11. Lee GR, Nacht S, Lukens JN, et al . Iron metabolism in copper-deficient swine. J Clin Invest 1968;47:2058-69.
12. Cherukuri S, Tripoulas NA, Nurko S, et al. Anemia and impaired stress-induced erythropoiesis in aceruloplasminemic mice. Blood Cells Mol Dis 2004;33:346-55. (Pubitemid 39446510)
13. Klebanoff SJ. Bactericidal effect of Fe2+, ceruloplasmin, and phosphate. Arch Biochem Biophys 1992;295:302-8.
14. Harris ZL, Takahashi Y, Miyajima H, et al. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A 1995;92:2539-43.
15. Harris ZL, Klomp LW, Gitlin JD. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr 1998;67:972S-7S. (Pubitemid 28198819)
16. Harris ZL, Durley AP, Man TK, et al. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci U S A 1999;96:10812-17. (Pubitemid 29442226)
17. Mukhopadhyay CK, Attieh ZK, Fox PL. Role of ceruloplasmin in cellular iron uptake. Science 1998;279:714-17. (Pubitemid 28144552)
18. Qian Y, Liu C, Hartupee J, et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 2007;8:247-56. (Pubitemid 46745374)
19. Xiao H, Gulen MF, Qin J, et al. The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 2007;26:461-75. (Pubitemid 46602997)
20. Yamamoto K, Yoshida K, Miyagoe Y, et al. Quantitative evaluation of expression of iron-metabolism genes in ceruloplasmin-deficient mice. Biochim Biophys Acta 2002;1588:195-202. (Pubitemid 35223462)
21. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29. (Pubitemid 34851835)
22. Hans W, Scholmerich J, Gross V, et al. The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur J Gastroenterol Hepatol 2000;12:267-73. (Pubitemid 30168579)
23. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-41. (Pubitemid 38962578)
24. Texel SJ, Xu X, Harris ZL. Ceruloplasmin in neurodegenerative diseases. Biochem Soc Trans 2008;36:1277-81.
25. Patel BN, Dunn RJ, Jeong SY, et al. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci 2002;22:6578-86. (Pubitemid 35386414)
26. Cherukuri S, Potla R, Sarkar J, et al. Unexpected role of ceruloplasmin in intestinal iron absorption. Cell Metab 2005;2:309-19.
27. Fleming RE, Whitman IP, Gitlin JD. Induction of ceruloplasmin gene expression in rat lung during inflammation and hyperoxia. Am J Physiol 1991;260:L68-74.
28. Ehrenwald E, Fox PL. Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells. J Clin Invest 1996;97:884-90. (Pubitemid 26057109)
29. Sarkar J, Seshadri V, Tripoulas NA, et al. Role of ceruloplasmin in macrophage iron efflux during hypoxia. J Biol Chem 2003;278:44018-24. (Pubitemid 37377141)
30. Chevion M, Berenshtein E, Stadtman ER. Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic Res 2000;33:99S-108S.
31. Babbs CF. Oxygen radicals in ulcerative colitis. Free Radic Biol Med 1992;13:169-81.
32. Patel BN, David S. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J Biol Chem 1997;272:20185-90. (Pubitemid 27340128)
33. Kaneko K, Nakamura A, Yoshida K, et al. Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain. Free Radic Res 2002;36:303-6. (Pubitemid 35154074)
34. Yoshida K, Kaneko K, Miyajima H, et al. Increased lipid peroxidation in the brains of aceruloplasminemia patients. J Neurol Sci 2000;175:91-5. (Pubitemid 30265474)
35. Hochstrasser H, Tomiuk J, Walter U, et al. Functional relevance of ceruloplasmin mutations in Parkinson's disease. FASEB J 2005;19:1851-3. (Pubitemid 41598772)
36. Shim H, Harris ZL. Genetic defects in copper metabolism. J Nutr 2003;133:1527S-31S. (Pubitemid 36548740)
37. Meyer LA, Durley AP, Prohaska JR, et al. Copper transport and metabolism are normal in aceruloplasminemic mice. J Biol Chem 2001;276:36857-61.
38. Miyajima H, Kohno S, Takahashi Y, et al. Estimation of the gene frequency of aceruloplasminemia in Japan. Neurology 1999;53:617-19. (Pubitemid 29382060)
39. McNeill A, Pandolfo M, Kuhn J, et al. The neurological presentation of ceruloplasmin gene mutations. Eur Neurol 2008;60:200-5.
40. Miyajima H, Kono S, Takahashi Y, et al. Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation. Neurology 2001;57:2205-10. (Pubitemid 34016452)
41. de Bie P, Muller P, Wijmenga C, et al. Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J Med Genet 2007;44:673-88. (Pubitemid 350161581)
42. Scheinberg IH. Wilson's Disease: W. B Saunders, Philadelphia, PA, USA, 1984.
43. Ala A, Walker AP, Ashkan K, et al. Wilson's disease. Lancet 2007;369: 397-408. (Pubitemid 46177228)
44. Dahlman T, Hartvig P, Lofholm M, et al. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine). Q J Med 1995;88:609-16.
45. Torisu T, Esaki M, Matsumoto T, et al. A rare case of ulcerative colitis complicating Wilson's disease: possible association between the two diseases. J Clin Gastroenterol 2002;35:43-5. (Pubitemid 34663349)
46. Dieleman LA, Ridwan BU, Tennyson GS, et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994;107:1643-52. (Pubitemid 24357616)
47. Qualls JE, Kaplan AM, van Rooijen N, et al. Suppression of experimental colitis by intestinal mononuclear phagocytes. J Leukoc Biol 2006;80:802-15. (Pubitemid 44835899)
48. Bernasconi E, Favre L, Maillard MH, et al. Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote efficient colonic mucosal healing. Inflamm Bowel Dis 2010;16:428-41.
49. Sainathan SK, Hanna EM, Gong Q, et al. Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. Inflamm Bowel Dis 2008;14:88-99. (Pubitemid 351196873)
50. Ito R, Shin-Ya M, Kishida T, et al. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin Exp Immunol 2006;146:330-8. (Pubitemid 44581349)
51. Krieglstein CF, Anthoni C, Cerwinka WH, et al. Role of blood- and tissue-associated inducible nitric-oxide synthase in colonic inflammation. Am J Pathol 2007;170:490-6. (Pubitemid 47339386)
52. Smith P, Mangan NE, Walsh CM, et al. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol 2007;178:4557-66. (Pubitemid 46492408)
53. Hunter MM, Wang A, Parhar KS, et al. In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology 2010;138:1395-405.